Hypertension, lipoprotein(A), and apolipoprotein a-i as risk factors for stroke in the chinese

Stroke

Volumn 22, Issue 2, 1991, Pages 203-208

  Woo, J ^a   Lau, E ^b   Lam, C ^c   Kay, R ^a   Teoh, R ^a   Wong, H Y ^a   Prall, W Y ^a   Kreel, L ^d   Nicholls, M G ^a  

^a Departments of Medicine   (China)

^b Community Medicine ^*  (China)

^c Chemical Pathology   (China)

^d CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIURETIC AGENT; LIPOPROTEIN A; METHYLDOPA;

ADULT; AGED; ARTICLE; DIABETES MELLITUS; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RISK FACTOR; STROKE;

APOLIPOPROTEIN A-I; APOLIPOPROTEINS A; CASE-CONTROL STUDIES; CEREBROVASCULAR DISORDERS; CHINA; COMPARATIVE STUDY; HONG KONG; HUMAN; HYPERTENSION; LIPOPROTEIN(A); LIPOPROTEINS; LIPOPROTEINS, HDL; MIDDLE AGE; OSMOLAR CONCENTRATION; RISK FACTORS; SUPPORT, NON-U.S. GOV'T;

EID: 0025971743     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/01.STR.22.2.203     Document Type: Article

References (28)

1. Tell GS, Crouse JR, Furberg CD: Relation between blood lipids, lipoproteins, and cerebrovascular atherosclerosis: A review. Stroke 1988; 19:423-430
2. Wolf PA, Kannel WB, Verter J: Current risk factors for stroke. Neurol Clin 1983;1:317-343
3. Dyken ML, Wolf PA, Barnet HJM, Bergan JJ, Hass WK, Kannel WB, Kuller L, Kurtzke JF, Sundt TM: Risk factors in stroke. A statement for physicians by the Subcommittee on Risk Factors and Stroke of the Stroke Council. Stroke 1984; 15:1105-1111
4. Khaw KT, Barrett-Connor E: Family history of stroke as an independent predictor of ischemic heart disease in men and stroke in women. Am J Epidemiol 1986; 123:59-66
5. Shinton R, Beevers G: Meta-analysis of relation between cigarette smoking and stroke. Br Med J 1989;298:789-794
6. Halperin JL, Hart RG: Atrial fibrillation and stroke: New ideas, persisting dilemmas. Stroke 1988;19:937-941
7. Bamford J, Sandercock P, Jones L, Warlow C: The natural history of lacunar infarction: The Oxford Community Stroke Project. Stroke 1987; 18:545-551
8. 2 precipitation technique in human serum. Clin Chim Acta 1986;158:33-41
9. Friedewald WT, Levy RI, Frederickson DS: Estimation of plasma low density lipoprotein cholesterol concentration without the use of the preparative ultracentrifuge. Clin Chem 1972;18:499-512
10. Woo J, Lam CWK, Kay R, Wong HY, Teoh R, Nicholls MG: Acute and long-term changes in serum lipids after acute stroke. Stroke 1990;21:1407-1411
11. Walter SD: Calculation of attributable risks from epidemio-logical data. Int J Epidemiol 1987;7:175-182
12. Woo J, Ho SC, Donnan SPB, Swaminathan R: Nutritional correlates of blood pressure in elderly Chinese. J Hum Hyper-tens 1988; 1:287-291
13. Hollanders ED, Shafar J: Serum lipid changes following the completed stroke syndrome. Postgrad Med J 1975;51:386-389
14. Mendez I, Hachinski V, Wolfe B: Serum lipids after stroke. Neurology 1987;37:507-511
15. Adams RJ, Carroll RM, Nichols FT, McNair N, Feldman DS, Feldman EB, Thompson WO: Plasma lipoproteins in cortical versus lacunar infarction. Stroke 1989;20:448-452
16. Ames RP: Antihypertensive drugs and lipid profiles. Am J Hypertens 1988;1:421-427
17. Kesteloot H, Huang DX, Yang XS, Claes J, Rosseneu M, Geboers J, Joossens JV: Serum lipids in the People’s Republic of China. Comparison of western and eastern populations. Arteriosclerosis 1985;5:427-433
18. Meyer JS, Rogers RL, Mortel KF, Judd BW: Hyperlipidemia is a risk factor for decreased cerebral perfusion and stroke. Arch Neurol 1987;44:418-422
19. Salonen JT, Puska P: Relation of serum cholesterol and triglycerides to the risk for acute myocardial infarction, cerebral stroke and death in eastern Finnish male population. Int J Epidemiol 1983;12:26-31
20. Iso H, Jacobs DR, Wentworth D, Neaton JD, Cohen JD: Serum cholesterol levels and six-year mortality from stroke in 350,977 men screened for the Multiple Risk Factor Intervention Trial. N Engl J Med 1989;320:904-910
21. Szatrowski TP, Peterson AV, Shimizu Y, Prentice RL, Mason MW, Fukunaga Y, Kato H: Serum cholesterol and other risk factors and cardiovascular disease in a Japanese cohort. J Chronic Dis 1984;37:569-584
22. Rhoads GA, Feinleib M: Serum triglyceride and risk of coronary heart disease, stroke and total mortality in Japanese-American men. Arteriosclerosis 1983;3:316-322
23. Murai A, Tanaka T, Miyahara T, Kameyama M: Lipoprotein abnormalities in the pathogenesis of cerebral infarction and transient ischemic attack. Stroke 1981;12:167-172
24. Murai A, Miyahara T, Fujimoto N, Matsuda M, Kameyama M: Lp(a) lipoprotein as a risk factor for coronary heart disease and cerebral infarction. Atherosclerosis 1986;59:199-204
25. Avogaro P, Cazzolato G, Bon GB, Quinci GB: Are apolipo-proteins better discriminators than lipids for atherosclerosis? Lancet 1979;1:901-903
26. Brewer HB, Gregg RE, Hoeg JM, Fojo SS: Apolipoproteins and lipoproteins in human plasma: A review. Clin Chem 1988;34:B4-B8
27. Yiu Y, Aoyama T, Morishita H, Takahashi M, Takatsu Y, Kawai C: Serum prostacyclin stabilizing factor is identical to apolipoprotein A-I (Apo A-I). J Clin Invest 1988;82:803-807
28. Asplund K, Dahlen G, Olsson T, Viitanen M: Lipoprotein(a) and its relation to hypertension in patients with acute stroke. Stroke 1990;21(suppl I):1-91